Tech Alert: TGA Consultations – Regulatory options to allow references to the TGA in advertising; DAEN user survey 

Two TGA consultations have recently been announced:

Regulatory options to potentially allow references to the TGA in therapeutic goods advertising

This Public Consultation, closing 7 November 2022, considers potential options on whether allowing references to the TGA in therapeutic goods advertising (and on product labels) may support consumers to make better informed health decisions by more clearly identifying products that have met the regulatory requirements and are being lawfully advertised and sold.

The TGA are seeking feedback on:

– whether references to the TGA should be allowed in therapeutic goods advertising the class or classes of therapeutic goods, if any, that should be allowed to refer to the TGA;

– options for what a reference to the TGA could look like;

– options for how an authorised reference to TGA may be used in advertising; and

– whether references to TGA should be optional or mandatory for advertisers.

DAEN user experience survey

This online survey, closing 26 October 2022, is seeking feedback on stakeholder experience of the beta version of the database of adverse events notifications (DAEN), providing the opportunity for stakeholders to identify any areas of the beta version that are problematic or not fit for purpose prior to implementation.

Please read today’s full technical alert for more information and details.



Vale Stephen Myers

It is with great sadness that we learned of the passing of Emeritus Professor Stephen Myers late last week. Stephen was a giant in the

Read More